-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Insulet, Lowers Price Target to $245

Benzinga·07/13/2026 14:20:04
語音播報
RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $280 to $245.